SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-14-082131
Filing Date
2014-03-04
Accepted
2014-03-04 15:22:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 8-A12B d664399d8a12b.htm 8-A12B 12102
3 GRAPHIC g664399logo_cov.jpg GRAPHIC 6271
  Complete submission text file 0001193125-14-082131.txt   21957
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldexa Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-36332 | Film No.: 14664367
SIC: 2834 Pharmaceutical Preparations